<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2466-2-4.anc" start="19701" end="19708" sStart="-1" offset="0" sid="null" wn="1 2" wnkey="null" text="Further we have collaboratively &lt;b&gt;written&lt;/b&gt; the manuscript and take public responsibility for it." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2466-2-4.anc" start="19701" end="19708" sStart="null" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" text="Further we have collaboratively &lt;b&gt;written&lt;/b&gt; the manuscript and take public responsibility for it." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2466-2-4.anc" start="19701" end="19708" sStart="null" offset="0" sid="null" wn="1" wnkey="write%2:36:00::" text="Further we have collaboratively &lt;b&gt;written&lt;/b&gt; the manuscript and take public responsibility for it." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="16119" end="16128" sStart="null" offset="20" sid="r8.suggest.v.0449" wn="1" wnkey="suggest%2:32:00::" text="It has been suggested that the immune response in tuberculosis may be closely related to differences between females and males in type and concentration of non-sex steroid and sex steroid hormones secreted [ 27 ] , the direction of this response difference is, however, unclear." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2466-2-4.anc" start="14294" end="14299" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="This is consistent with observations in other settings where tuberculosis has been &lt;b&gt;shown&lt;/b&gt; to occur more among younger females than males, and in persons of lower body mass indices [ 22 ] . However, in our study cohort, female patients had higher serum ? 2 microglobulin levels at the &lt;b&gt;time&lt;/b&gt; of diagnosis with tuberculosis, suggesting a possibly higher HIV burden [ 23 24 ] , than male patients despite comparable CD4 lymphocyte counts." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2466-2-4.anc" start="14294" end="14299" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="This is consistent with observations in other settings where tuberculosis has been &lt;b&gt;shown&lt;/b&gt; to occur more among younger females than males, and in persons of lower body mass indices [ 22 ] . However, in our study cohort, female patients had higher serum ? 2 microglobulin levels at the &lt;b&gt;time&lt;/b&gt; of diagnosis with tuberculosis, suggesting a possibly higher HIV burden [ 23 24 ] , than male patients despite comparable CD4 lymphocyte counts." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="14958" end="14964" sStart="null" offset="81" sid="r11.severe.j.0385" wn="1" wnkey="severe%5:00:00:intense:00" text="Studies have suggested that tuberculosis and HIV may have a particularly severe impact on young women in a low-income setting [ 25 ] . We did not find that HIV-infected women fared any worse from tuberculosis than men." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="3968" end="3979" sStart="null" offset="267" sid="r11.recommend.v.0475" wn="1" wnkey="recommend%2:32:01::" text="All patients received anti-tuberculosis treatment consisting of two months of daily self-administered isoniazid (INH), rifampicin, ethambutol, and pyrazinamide, followed by six months of daily INH and rifampicin, which was the recommended first line treatment by the World Health Organization (WHO)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="2757" end="2763" sStart="null" offset="90" sid="r8.number.n.0168" wn="1" wnkey="number%1:07:00::" text="Of these, 50% were estimated to have tuberculosis co-infection [ 14 ] . The total number of notifications of tuberculosis cases of all forms has been steadily rising in Uganda, from 14,740 in 1990 to 27,196 in 1996 (an increase of over 90%), even with an estimated case detection rate of about 44% [ 15 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="11180" end="11186" sStart="null" offset="172" sid="r9.level.n.0977" wn="1" wnkey="level%1:07:00::" text="In addition, patients with a favorable outcome had larger PPD skin test reactions, higher absolute CD4+ cell counts, lower serum ? 2 microglobulin levels, and were more likely to have fibrotic changes on their initial chest x-ray, than subjects with an unfavorable outcome." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="14513" end="14519" sStart="null" offset="318" sid="r9.level.n.0373" wn="1" wnkey="level%1:07:00::" text="This is consistent with observations in other settings where tuberculosis has been shown to occur more among younger females than males, and in persons of lower body mass indices [ 22 ] . However, in our study cohort, female patients had higher serum ? 2 microglobulin levels at the time of diagnosis with tuberculosis, suggesting a possibly higher HIV burden [ 23 24 ] , than male patients despite comparable CD4 lymphocyte counts." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="10148" end="10154" sStart="null" offset="97" sid="r9.level.n.0224" wn="2" wnkey="level%1:26:01::" text="However, female patients had significantly higher mean serum ? 2 -microglobulin levels, while male patients had significantly higher hemoglobin levels." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="725" end="730" sStart="null" offset="682" sid="r9.kill.v.0760" wn="4" wnkey="kill%2:42:00::" text="Tuberculosis is estimated to cause at least three million deaths per year worldwide [ 1 ] and also accounts for more than one-quarter of all preventable adult deaths in developing countries [ 2 ] . Infection with the human immuno-deficiency virus (HIV) is thought to be the single most important factor that has contributed to the increased incidence of tuberculosis globally in the last decade [ 2 ] . Tuberculosis is now the leading cause of death among HIV-infected individuals worldwide and accounts for at least 40% of deaths among HIV-infected persons in Africa [ 3 ] . Furthermore, tuberculosis kills more women than any other infectious disease, including malaria and AIDS [ 4 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8265" end="8274" sStart="null" offset="234" sid="r1.influence.n.0064" wn="4" wnkey="influence%1:19:00::" text="We evaluated the bivariate relationships between gender and outcome with selected baseline covariates, and constructed a time-series repeated measures regression model [ 20 21 ] to describe the influence of gender on the outcome using data at baseline and two, six, nine and 12 months." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8591" end="8600" sStart="null" offset="83" sid="r1.influence.n.0047" wn="4" wnkey="influence%1:19:00::" text="A proportional-hazards regression model was used to assess the influence of gender on one-year survival." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8265" end="8274" sStart="null" offset="234" sid="r1.influence.n.0064" wn="4" wnkey="influence%1:19:00::" text="We evaluated the bivariate relationships between gender and outcome with selected baseline covariates, and constructed a time-series repeated measures regression model [ 20 21 ] to describe the influence of gender on the outcome using data at baseline and two, six, nine and 12 months." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8591" end="8600" sStart="null" offset="83" sid="r1.influence.n.0047" wn="4" wnkey="influence%1:19:00::" text="A proportional-hazards regression model was used to assess the influence of gender on one-year survival." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8265" end="8274" sStart="null" offset="234" sid="r1.influence.n.0064" wn="2" wnkey="influence%1:04:00::" text="We evaluated the bivariate relationships between gender and outcome with selected baseline covariates, and constructed a time-series repeated measures regression model [ 20 21 ] to describe the influence of gender on the outcome using data at baseline and two, six, nine and 12 months." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="8591" end="8600" sStart="null" offset="83" sid="r1.influence.n.0047" wn="2" wnkey="influence%1:04:00::" text="A proportional-hazards regression model was used to assess the influence of gender on one-year survival." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="18590" end="18594" sStart="null" offset="209" sid="r10.high.j.0472" wn="1" wnkey="high%3:00:02::" text="The third potential limitation is that serum ? 2 microglobulin levels have not been shown to be associated with survival in HIV-infected patients on antiretroviral treatment, although high levels generally imply a higher burden of HIV infection." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="17771" end="17780" sStart="null" offset="148" sid="r8.1.different.j.0156" wn="4" wnkey="different%5:00:01:other:00" text="Using the repeated measures model methodology [ 20 21 ] allowed us to use more data points, since each covariate was updated at the different time points, and it gave us more power and a more robust estimation of the effect of gender on outcome than using baseline covariates would have done." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2466-2-4.anc" start="7084" end="7090" sStart="null" offset="145" sid="r10.board.n.0497" wn="1" wnkey="board%1:14:00::" text="The study protocol was reviewed and approved by the Ugandan National AIDS Research Subcommittee and the institutional review boards of Case Western Reserve University and University Hospitals of Cleveland." />
  </sentences>
</list>